Ftse Mib
34.272,26
0,33%
DAX
19.957,31
-0,01%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
93.710,91
0,20%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX IGC Pharma Inc (IGC) IGC Pharma Inc (IGC) Notizie

IGC Pharma Inc

IGC
0,38
0,01 (2,70%)
Pre Mercato
Ultimo aggiornamento: 12:35:28
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/11/202414:30BWIGC Pharma Announces Additional Phase 2 Interim Results..
12/11/202422:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/9/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:05EDGAR2Form 8-K - Current report
18/9/202414:00BWIGC Pharma Announces Additional Data Supporting IGC-AD1 as..
04/9/202414:00BWIGC Pharma Advances IGC-AD1 Toward Clinical Trials as a..
27/8/202401:00BWIGC Announces Results of its 2024 Annual Stockholders..
22/8/202415:00BWIGC Pharma Announces Research Demonstrating New Molecule..
20/8/202414:00BWIGC Pharma Expands Drug Portfolio to Metabolic Disorders..
14/8/202422:23EDGAR2Form SC 13D/A - General Statement of Acquisition of..
09/8/202403:30BWIGC Pharma Reports First Quarter Fiscal 2025 Results
07/8/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202420:38EDGAR2Form 8-K - Current report
18/7/202415:00BWIGC Pharma Announces Equity Analyst Coverage by Alliance..
09/7/202420:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/7/202415:10BWPreclinical Analyses of TGR-63 Demonstrate Blood-Brain..
08/7/202422:07EDGAR2Form DEF 14A - Other definitive proxy statements
25/6/202415:00BWIGC Pharma's TGR-63 Preclinical Results Show Substantial..
25/6/202401:30BWIGC Reports Financial Results for Fiscal Year Ended March..
18/6/202415:00BWIGC Pharma to Participate in Fireside Chat with Ascendiant..
10/6/202415:00BWIGC Pharma Publishes Study in European Society of Medicine..
28/5/202415:00BWIGC Pharma Announces Patient Enrollment at Neurostudies in..
22/5/202403:20EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/5/202420:00BWIGC Pharma to Attend BIO International Convention 2024
14/5/202403:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202403:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/4/202413:00BWIGC-AD1’s Interim Phase 2 Data Show a Reduction in..
09/4/202415:00BWIGC Pharma Adds Advisor in Artificial Intelligence
26/3/202420:00BWIGC Pharma Announces $3 Million Unregistered Private..
20/3/202416:00BWIGC Pharma Announces Positive Interim Results for IGC-AD1 in..
20/3/202412:00BWIGC PHARMA Announces its Participation at the Benzinga..
12/3/202420:00BWIGC Pharma (IGC): Healthcare Leader Terry Lierman Joins..
28/2/202419:00BWPromising Results: TGR-63 Enhances Memory in Alzheimer's..
23/2/202418:01BWIGC Pharma Announces Equity Analyst Coverage by Ascendiant..
17/2/202401:05BWIGC Pharma Reports Third Quarter Fiscal 2024 Results
14/2/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/2/202415:20BWIGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's..
31/1/202422:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/1/202415:20BWIGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63..
17/1/202415:20BWIGC Pharma Activates ClinCloud, One of 12 Sites in Ongoing..
Apertura: Min: Max:
Chiusura: 0,37

La tua Cronologia

AMEX
IGC
IGC Pharma
EU
KORAF
Kempen Orange Fund Nv
LATK
BRCUSDT
Bisercoin
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network